Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Akiko Furusawa
Observed name:
Akiko FURUSAWA
Institutions:
Tokyo Metropolitan Komagome Hospital,
Shizuoka Cancer Center
Observed institutions:
Tokyo Medical and Dental University,
Tokyo Metropolitan Komagome Hospital,
Shizuoka Cancer Center,
Tsuchiura Kyodo General Hospital
ORCID:
0000-0003-1279-4971
Observed ORCID:
0000-0003-1279-4971
OpenAlex ID:
A5047498319
A low albumin to globulin ratio with a high serum globulin level is a prognostic marker for poor survival in cervical cancer patients treated with radiation based therapy
2019
·
Yasunori Yoshino
, Ayumi Taguchi
, et al.
·
International Journal of Gynecological Cancer
·
50
Ovarian cancer therapeutic potential of glutamine depletion based on GS expression
2018
·
Akiko Furusawa
, Morikazu Miyamoto
, et al.
·
Carcinogenesis
·
41
Profile of treatment-related complications in women with clinical stage IB-IIB cervical cancer: A nationwide cohort study in Japan
2019
·
Hiroko Machida
, Koji Matsuo
, et al.
·
PLoS ONE
·
28
PDF
Selection bias due to delayed comprehensive genomic profiling in Japan
2022
·
Taichi Tamura
, Masachika Ikegami
, et al.
·
Cancer Science
·
27
PDF
Development of a deep learning method for improving diagnostic accuracy for uterine sarcoma cases
2022
·
Yusuke Toyohara
, Kenbun Sone
, et al.
·
Scientific Reports
·
24
PDF
Postradiotherapy persistent lymphopenia as a poor prognostic factor in patients with cervical cancer receiving radiotherapy: a single-center, retrospective study
2020
·
Ayumi Taguchi
, Akiko Furusawa
, et al.
·
International Journal of Clinical Oncology
·
24
Practice patterns of adjuvant therapy for intermediate/high recurrence risk cervical cancer patients in Japan
2016
·
Yuji Ikeda
, Akiko Furusawa
, et al.
·
Journal of Gynecologic Oncology
·
24
PDF
Rare case of endometrioid adenocarcinoma arising from cystic adenomyosis
2014
·
Mayuyo Mori
, Akiko Furusawa
, et al.
·
Journal of obstetrics and gynaecology research
·
21
A randomized phase III trial of adjuvant chemotherapy versus concurrent chemoradiotherapy for postoperative cervical cancer: Japanese Gynecologic Oncology Group study (JGOG1082)
2021
·
Akiko Furusawa
, Munetaka Takekuma
, et al.
·
International Journal of Gynecological Cancer
·
20
Extreme skeletal muscle loss during induction chemotherapy is an independent predictor of poor survival in advanced epithelial ovarian cancer patients
2020
·
Yasunori Yoshino
, Ayumi Taguchi
, et al.
·
Journal of obstetrics and gynaecology research
·
17
Phase I/II study of stereotactic body radiotherapy boost in patients with cervical cancer ineligible for intracavitary brachytherapy
2024
·
Kei Ito
, Yujiro Nakajima
, et al.
·
Japanese Journal of Radiology
·
11
PDF
The concept of platinum sensitivity could be applied to recurrent cervical cancer: a multi-institutional retrospective study from the Japanese Gynecologic Oncology Group
2017
·
Munetaka Takekuma
, Keita Mori
, et al.
·
Cancer Chemotherapy and Pharmacology
·
10
Heterogeneous treatment effects of adjuvant therapy for patients with cervical cancer in the intermediate‐risk group
2023
·
Ayumi Taguchi
, Kosuke Kato
, et al.
·
Cancer Medicine
·
9
PDF
High neutrophil‐to‐lymphocyte ratio is a predictor of short‐term survival for patients with recurrent cervical cancer after radiation‐based therapy
2021
·
Ayumi Taguchi
, Yujiro Nakajima
, et al.
·
Journal of obstetrics and gynaecology research
·
9
Lymphopenia after induction chemotherapy correlates with incomplete surgical resection in patients with advanced ovarian cancer
2018
·
Yasunori Yoshino
, Ayumi Taguchi
, et al.
·
International Journal of Clinical Oncology
·
7
Heterogeneous treatment effect of dose‐dense paclitaxel plus carboplatin therapy for advanced ovarian cancer
2024
·
Ayumi Taguchi
, Kosuke Kato
, et al.
·
International Journal of Cancer
·
5
A survey of carboplatin desensitization therapy in Japan: A multicenter retrospective study
2024
·
Hiroaki Komatsu
, Koji Matsumoto
, et al.
·
Cancer Medicine
·
4
PDF
Optimizing treatment for platinum‐resistant ovarian clear cell carcinoma: Efficacy of gemcitabine and combination therapy with bevacizumab
2025
·
Yasunori Yoshino
, Akiko Furusawa
, et al.
·
Cancer
·
3
PDF
Cytology of salivary gland tumors, cytologic findings in connection with histopathology. Fine needle aspiration cytology of Warthin's tumor.
2001
·
Shojiroh MORINAGA
, Hideki ORIKASA
, et al.
·
日本臨床細胞学会雑誌
·
2
PDF
Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial
2026
·
Domenica Lorusso
, Jérôme Martin-Babau
, et al.
·
The Lancet
·
1
Exceptional Response to Lenvatinib plus Pembrolizumab after Pembrolizumab Failure in MLH1-Methylated Deficient Mismatch Repair/Microsatellite Instability-High Endometrial Cancer: A Case Report
2026
·
Natsuko Kamiya
, Munetaka Takekuma
, et al.
·
Case Reports in Oncology
·
1
PDF
Impact of the FIGO2023 staging system on endometrial cancer in Japan: differences between next-generation sequencing and simplified surrogate marker analysis
2024
·
Ryoken Nara
, Akiko Furusawa
, et al.
·
Japanese Journal of Clinical Oncology
·
1
PDF
Clinicopathological demographics of malignant melanoma of the vulva and vagina in Japan: Japanese Gynecologic Oncology Group (JGOG)/Japanese Skin Cancer Society (JSCS)—Intergroup Study.
2020
·
Shin Nishio
, Dai Ogata
, et al.
·
Journal of Clinical Oncology
·
1
Long-term results of stereotactic body radiotherapy boost in patients with cervical cancer considered unsuitable for intracavitary brachytherapy
2026
·
Kei Ito
, Yujiro Nakajima
, et al.
·
Japanese Journal of Radiology
PDF
Early-onset pyomyoma mimicking post-embolization syndrome after uterine artery embolization: a case report and review of the literature
2026
·
Koji Ohyama
, Akiko Furusawa
, et al.
·
Journal of Infection and Chemotherapy
Show more works
View as search
Works count:
42
Citation count:
340
H-index:
11
I10-index:
12
Year
Topic
Type